Bill Snyder

James Crowe Jr., MD, and colleagues are exploring how the body’s immune system gears up to fight off infection.
October 13, 2020

COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials

AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca.

By Bill Snyder
October 8, 2020

Computer-based study reveals impact of race on health

A computer-based method developed at Vanderbilt University Medical Center that scans electronic medical records (EMRs) for genetic contributors to disease has been used for the first time to reveal the impact of race on health.

By Bill Snyder
Michelle Southard-Smith, PhD, Aaron May-Zhang, PhD, and colleagues have created a molecular ‘atlas’ of genes expressed by the neuronal cells within the intestine that coordinate the functions of the gastrointestinal (GI) tract.
October 8, 2020

Researchers create molecular ‘atlas’ of GI tract neurons

Researchers at Vanderbilt University Medical Center have generated the first comprehensive molecular “atlas” of genes expressed by the neuronal cells within the intestine that coordinate the functions of the gastrointestinal (GI) tract.

By Bill Snyder
October 7, 2020

Vanderbilt Prize winner Doudna awarded Nobel Prize in Chemistry

University of California, Berkeley, biochemist Jennifer Doudna, PhD, recipient of the 2020 Vanderbilt Prize in Biomedical Science, has been awarded the 2020 Nobel Prize in Chemistry.

By Bill Snyder
October 6, 2020

Bick receives NIH Director’s Early Independence Award

Alexander Bick, MD, PhD, a new faculty member in the Division of Genetic Medicine at Vanderbilt University Medical Center, has received a 2020 National Institutes of Health (NIH) Director’s Early Independence Award.

By Bill Snyder
October 5, 2020

Nominations sought for 2021 Vanderbilt Prize in Biomedical Science

Nominations for the 2021 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Dec. 11.

By Bill Snyder
September 24, 2020

REDCap helps state of Washington scale up its testing capacity

Until it was eclipsed by New York in mid-April, the state of Washington had the highest absolute number of COVID-19 cases in the United States.
By Bill Snyder
September 24, 2020

Cohen Fund bolsters Siciliano’s memory research

Cody Siciliano, PhD, assistant professor of Pharmacology in the Vanderbilt University School of Medicine, has been selected to receive a one-year, $100,000 research award from the Stanley Cohen Innovation Fund to support his studies of the neural substrates of memory.
By Bill Snyder
September 18, 2020

The Molecular Infectious Disease Lab team earns spotlight for work on COVID-19 diagnostic testing

The first suspected case of COVID-19 was detected in Tennessee March 5. Within four days, the lab team identified a testing platform, obtained reagents and developed and validated the test. By the end of the first 10 days, more than 3,300 tests had been completed.
By Bill Snyder
September 17, 2020

Grant from Google to support COVID gene expression study

Vanderbilt University Medical Center and the University of North Carolina (UNC) at Chapel Hill have been awarded $500,000 by Google’s philanthropy, Google.org, to study how COVID-19 alters gene expression in some people in ways that may be linked to their risk of severe illness and death.
By Bill Snyder
September 16, 2020

Nominations sought for Research Staff Awards

Nominations are being accepted for the 2020 Vanderbilt University School of Medicine Research Staff Awards.
By Bill Snyder
September 3, 2020

New clue to Alzheimer’s disease

Combining studies of genetically diverse mouse populations and human data led to the identification of a gene associated with cognitive decline and brain changes in Alzheimer’s disease.
By Bill Snyder
1 … 35 36 37 38 39 … 115